These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36051323)

  • 1. Prediction of Five-Year Cardiovascular Disease Risk in People with Type 2 Diabetes Mellitus: Derivation in Nanjing, China and External Validation in Scotland, UK.
    Wan C; Read S; Wu H; Lu S; Zhang X; Wild SH; Liu Y
    Glob Heart; 2022; 17(1):46. PubMed ID: 36051323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Cardiovascular Disease Risk Scores in People Diagnosed With Type 2 Diabetes: External Validation Using Data From the National Scottish Diabetes Register.
    Read SH; van Diepen M; Colhoun HM; Halbesma N; Lindsay RS; McKnight JA; McAllister DA; Pearson ER; Petrie JR; Philip S; Sattar N; Woodward M; Wild SH;
    Diabetes Care; 2018 Sep; 41(9):2010-2018. PubMed ID: 30002197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods.
    Dong W; Wan EYF; Fong DYT; Tan KC; Tsui WW; Hui EM; Chan KH; Fung CSC; Lam CLK
    Diabetes Obes Metab; 2024 Sep; 26(9):3969-3987. PubMed ID: 39010291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a cardiovascular diseases risk prediction model and tools for Chinese patients with type 2 diabetes mellitus: A population-based retrospective cohort study.
    Wan EYF; Fong DYT; Fung CSC; Yu EYT; Chin WY; Chan AKC; Lam CLK
    Diabetes Obes Metab; 2018 Feb; 20(2):309-318. PubMed ID: 28722290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a lifetime prediction model for incident type 2 diabetes in patients with established cardiovascular disease: the CVD2DM model.
    Helmink MAG; Peters SAE; Westerink J; Harris K; Tillmann T; Woodward M; van Sloten TT; van der Meer MG; Teraa M; Dorresteijn JAN; Ruigrok YM; Visseren FLJ; Hageman SHJ;
    Eur J Prev Cardiol; 2024 Oct; 31(14):1671-1678. PubMed ID: 38584392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2015 Nov; 351():h5441. PubMed ID: 26560308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary model for cardiovascular risk prediction in people with type 2 diabetes.
    Kengne AP; Patel A; Marre M; Travert F; Lievre M; Zoungas S; Chalmers J; Colagiuri S; Grobbee DE; Hamet P; Heller S; Neal B; Woodward M;
    Eur J Cardiovasc Prev Rehabil; 2011 Jun; 18(3):393-8. PubMed ID: 21450612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive performance of established cardiovascular risk scores in the prediabetic population: external validation using the UK Biobank data set.
    Li M; Lin Y; Zhong X; Huang R; Zhang S; Liu M; Liu S; Ye X; Xu X; Huang Y; Xiong Z; Guo Y; Liao X; Zhuang X
    Eur J Prev Cardiol; 2023 Oct; 30(14):1427-1438. PubMed ID: 37036042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 15. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk prediction models for incident type 2 diabetes in Chinese people with intermediate hyperglycemia: a systematic literature review and external validation study.
    Xu S; Coleman RL; Wan Q; Gu Y; Meng G; Song K; Shi Z; Xie Q; Tuomilehto J; Holman RR; Niu K; Tong N
    Cardiovasc Diabetol; 2022 Sep; 21(1):182. PubMed ID: 36100925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
    van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
    Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of type 2 diabetes risk in people with non-diabetic hyperglycaemia: model derivation and validation using UK primary care data.
    Coles B; Khunti K; Booth S; Zaccardi F; Davies MJ; Gray LJ
    BMJ Open; 2020 Oct; 10(10):e037937. PubMed ID: 33099496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESKD Risk Prediction Model in a Multicenter Chronic Kidney Disease Cohort in China: A Derivation, Validation, and Comparison Study.
    Hui M; Ma J; Yang H; Gao B; Wang F; Wang J; Lv J; Zhang L; Yang L; Zhao M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland.
    Malik MO; Govan L; Petrie JR; Ghouri N; Leese G; Fischbacher C; Colhoun H; Philip S; Wild S; McCrimmon R; Sattar N; Lindsay RS;
    Diabetologia; 2015 Apr; 58(4):716-25. PubMed ID: 25669630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.